These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 14742315)

  • 21. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
    Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
    Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells.
    Honma M; Zhang LS; Hayashi M; Takeshita K; Nakagawa Y; Tanaka N; Sofuni T
    Mol Cell Biol; 1997 Aug; 17(8):4774-81. PubMed ID: 9234733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements.
    Kantidze OL; Razin SV
    Gene; 2007 Apr; 391(1-2):76-9. PubMed ID: 17234368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
    Scian MJ; Stagliano KE; Anderson MA; Hassan S; Bowman M; Miles MF; Deb SP; Deb S
    Mol Cell Biol; 2005 Nov; 25(22):10097-110. PubMed ID: 16260623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
    Naoe T; Kudo K; Yoshida H; Horibe K; Ohno R
    Leukemia; 1997 Apr; 11 Suppl 3():287-8. PubMed ID: 9209367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
    Clifford B; Beljin M; Stark GR; Taylor WR
    Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of a t(8;14)(q24;q11) translocation juxtaposing c-myc and TcR-alpha genes in a T-cell leukaemia: involvement of a V alpha internal heptamer.
    Bernard O; Larsen CJ; Hampe A; Mauchauffé M; Berger R; Mathieu-Mahul D
    Oncogene; 1988 Feb; 2(2):195-200. PubMed ID: 2966921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of the recombination control and the sequence-specific transactivation function of P53.
    Dudenhöffer C; Kurth M; Janus F; Deppert W; Wiesmüller L
    Oncogene; 1999 Oct; 18(42):5773-84. PubMed ID: 10523858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The theory of APL.
    Piazza F; Gurrieri C; Pandolfi PP
    Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.
    Altabef M; Garcia M; Lavau C; Bae SC; Dejean A; Samarut J
    EMBO J; 1996 Jun; 15(11):2707-16. PubMed ID: 8654368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
    Slebos RJ; Taylor JA
    Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of wild-type p53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts.
    Willers H; McCarthy EE; Alberti W; Dahm-Daphi J; Powell SN
    Int J Radiat Biol; 2000 Aug; 76(8):1055-62. PubMed ID: 10947118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homologous and nonhomologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation.
    Gebow D; Miselis N; Liber HL
    Mol Cell Biol; 2000 Jun; 20(11):4028-35. PubMed ID: 10805745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotheses for testing deviations from random integration: evidence for nonrandom retroviral integration.
    Wilson AF; Cohen JC
    Genomics; 1988 Aug; 3(2):137-42. PubMed ID: 3224979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.
    Ho T; Tan BX; Lane D
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 in the DNA-Damage-Repair Process.
    Williams AB; Schumacher B
    Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Charged Particle Exposure on Homologous DNA Double-Strand Break Repair in Human Blood-Derived Cells.
    Rall M; Kraft D; Volcic M; Cucu A; Nasonova E; Taucher-Scholz G; Bönig H; Wiesmüller L; Fournier C
    Front Oncol; 2015; 5():250. PubMed ID: 26618143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism.
    Gole B; Wiesmüller L
    Front Cell Dev Biol; 2015; 3():41. PubMed ID: 26161385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endonuclease G initiates DNA rearrangements at the MLL breakpoint cluster upon replication stress.
    Gole B; Baumann C; Mian E; Ireno CI; Wiesmüller L
    Oncogene; 2015 Jun; 34(26):3391-401. PubMed ID: 25132265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.